Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Serum Albumin vs Human Serum Albumin in Cirrhotic Ascites
CTR20231314Phase 2Completed
- Sponsor
- Shenzhen Puruijin Biological Pharmaceutical Co., Ltd.
- Start
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human serum albumin in Cirrhosis, ascites, sponsored by Shenzhen Puruijin Biological Pharmaceutical Co., Ltd.. Started Apr 2023; status: completed.
02
Drugs
recombinant human serum albumin
03
Conditions
Cirrhosisascites
Beyond the preview
Go deeper on CTR20231314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231314.